ATE521365T1 - KININ ANTAGONISTS FOR THE TREATMENT OF BLADDER DISORDER - Google Patents

KININ ANTAGONISTS FOR THE TREATMENT OF BLADDER DISORDER

Info

Publication number
ATE521365T1
ATE521365T1 AT06754662T AT06754662T ATE521365T1 AT E521365 T1 ATE521365 T1 AT E521365T1 AT 06754662 T AT06754662 T AT 06754662T AT 06754662 T AT06754662 T AT 06754662T AT E521365 T1 ATE521365 T1 AT E521365T1
Authority
AT
Austria
Prior art keywords
treatment
bladder disorder
kinin antagonists
kinin
antagonists
Prior art date
Application number
AT06754662T
Other languages
German (de)
Inventor
Christoph Gibson
Gerd Hummel
Jochen Knolle
Ulrich Reineke
Thomas Tradler
Original Assignee
Jerini Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jerini Ag filed Critical Jerini Ag
Application granted granted Critical
Publication of ATE521365T1 publication Critical patent/ATE521365T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT06754662T 2005-07-05 2006-07-04 KININ ANTAGONISTS FOR THE TREATMENT OF BLADDER DISORDER ATE521365T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05014581A EP1741444A1 (en) 2005-07-05 2005-07-05 Kinin antagonists for treating bladder dysfunction
PCT/EP2006/006504 WO2007003411A2 (en) 2005-07-05 2006-07-04 Kinin antagonists for treating bladder dysfunction

Publications (1)

Publication Number Publication Date
ATE521365T1 true ATE521365T1 (en) 2011-09-15

Family

ID=34937780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06754662T ATE521365T1 (en) 2005-07-05 2006-07-04 KININ ANTAGONISTS FOR THE TREATMENT OF BLADDER DISORDER

Country Status (17)

Country Link
US (1) US20080221039A1 (en)
EP (2) EP1741444A1 (en)
JP (1) JP2009500362A (en)
KR (1) KR20080025120A (en)
CN (1) CN101212985A (en)
AR (1) AR054820A1 (en)
AT (1) ATE521365T1 (en)
AU (1) AU2006265266A1 (en)
BR (1) BRPI0613724A2 (en)
CA (1) CA2613627A1 (en)
IL (1) IL188316A0 (en)
RU (1) RU2008104134A (en)
SG (1) SG163564A1 (en)
TW (1) TW200800249A (en)
UA (1) UA96573C2 (en)
WO (1) WO2007003411A2 (en)
ZA (1) ZA200711240B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041963A1 (en) * 2004-10-15 2005-01-15 Luso Farmaco Inst "NON-PEPTIDIAL ANTAGONISTS OF BRADICHININ AND THEIR PHARMACEUTICAL COMPOSITIONS"
DE102005013967A1 (en) * 2004-11-05 2006-10-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg New imidazole or pyrimidine derivatives are bradykinin B1 antagonists used for treating e.g. pain, stroke, peptic ulcers and other inflammatory disorders
TWI407960B (en) 2007-03-23 2013-09-11 Jerini Ag Small molecule bradykinin b2 receptor modulators
FR2919803B1 (en) * 2007-08-07 2011-07-22 Sanofi Aventis USE OF A NON-PEPTIDE RECEPTOR B1 ANTAGONIST FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE TREATMENT OF OBESITY AND OBESITY OR DIABETES PATHOLOGIES
US20110046106A1 (en) * 2008-02-06 2011-02-24 Boehringer Ingelheim International Gmbh Aryl sulfonamides as effective analgesics
IT1391236B1 (en) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa PHARMACEUTICAL COMPOSITIONS BASED ON ANTAGONISTS OF THE B2 KININE AND CORTICOSTEROID RECEPTOR AND THEIR USE
US9415048B2 (en) 2010-07-08 2016-08-16 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US20130323288A1 (en) 2010-07-08 2013-12-05 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
MX2014008284A (en) * 2012-01-04 2015-03-03 Wellesley Pharmaceutical Llc Delayed-release formulation for reducing the frequency of urination and method of use thereof.
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
WO2014018223A1 (en) * 2012-07-27 2014-01-30 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
US10792326B2 (en) 2013-06-28 2020-10-06 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
JP6570521B2 (en) 2013-08-01 2019-09-04 ディグニファイ セラピューティクス エルエルシー Compositions and methods for inducing urination and defecation
CN103588861B (en) * 2013-10-25 2015-11-04 中国药科大学 The inhibiting peptide of New Delhi metallo-β-lactamase and application thereof
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
UY37981A (en) 2017-11-24 2019-06-28 Pharvaris B V NEW BRADIQUININE B2 RECEIVER ANTAGONISTS
AR118982A1 (en) 2019-05-23 2021-11-17 Pharvaris Gmbh CYCLIC BRADYKININ RECEPTOR ANTAGONISTS
UY38707A (en) 2019-05-23 2020-12-31 Pharvaris Gmbh NEW CYCLIC ANTAGONISTS OF BRADIQUININ B2 RECEPTOR

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9505491D0 (en) * 1995-03-18 1995-05-03 Merck Sharp & Dohme Therapeutic agents
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
EP1299101A4 (en) * 2000-06-28 2004-06-16 Teva Pharma Carvedilol
FR2822827B1 (en) * 2001-03-28 2003-05-16 Sanofi Synthelabo NOVEL N- (ARYLSULFONYL) BETA-AMINOACIDS DERIVATIVES COMPRISING A SUBSTITUTED AMINOMETHYL GROUP, THEIR PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US7063860B2 (en) * 2001-08-13 2006-06-20 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
DE60303441T2 (en) * 2002-02-08 2006-09-21 Merck & Co., Inc. N-BIPHENYLMETHYLAMINOCYCLOALKANCARBOXAMID-DERIVATIVE
US20040044041A1 (en) * 2002-08-06 2004-03-04 Kuduk Scott D. 2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives
CA2514581A1 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Methods of treating lower urinary tract disorders using sodium channel modulators
DK1590458T3 (en) * 2003-02-06 2013-02-04 Univ Belfast Bradykinin B2 receptor antagonist peptide from amphibian skin
JP2006520799A (en) * 2003-03-21 2006-09-14 ダイノジェン ファーマシューティカルズ， インコーポレイテッド Methods for treating lower urinary tract disorders using smooth muscle regulators and α2δ subunit calcium channel regulators

Also Published As

Publication number Publication date
ZA200711240B (en) 2008-08-27
WO2007003411A3 (en) 2007-05-18
AU2006265266A1 (en) 2007-01-11
UA96573C2 (en) 2011-11-25
IL188316A0 (en) 2008-04-13
RU2008104134A (en) 2009-08-10
EP1741444A1 (en) 2007-01-10
EP1901775B1 (en) 2011-08-24
AR054820A1 (en) 2007-07-18
BRPI0613724A2 (en) 2011-02-08
JP2009500362A (en) 2009-01-08
CA2613627A1 (en) 2007-01-11
US20080221039A1 (en) 2008-09-11
KR20080025120A (en) 2008-03-19
CN101212985A (en) 2008-07-02
WO2007003411A2 (en) 2007-01-11
SG163564A1 (en) 2010-08-30
EP1901775A2 (en) 2008-03-26
TW200800249A (en) 2008-01-01

Similar Documents

Publication Publication Date Title
ATE521365T1 (en) KININ ANTAGONISTS FOR THE TREATMENT OF BLADDER DISORDER
ATE493986T1 (en) DIARYLUREAS FOR THE TREATMENT OF PULMONARY HYPERTENSION
ATE527241T1 (en) PYRIDIAZINONE DERIVATIVES FOR THE TREATMENT OF TUMORS
ATE429218T1 (en) PINOLENEIC ACID FOR THE TREATMENT OF OBESITY
DE602006019560D1 (en) 2-CYANOBENZOLSULFONAMIDE COMPOUNDS FOR THE TREATMENT OF SEEDS
DE602005020209D1 (en) System for the evaluation of cardiac disorders
ATE550329T1 (en) HETEROBICYCLIC SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES
DE602005015234D1 (en) COMPOSITIONS FOR WASH TREATMENT
DE602005014252D1 (en) COMPOSITIONS FOR WASH TREATMENT
DE602005019899D1 (en) SYSTEM FOR THE TREATMENT OF ISCHEMIC STROKE
DE502006004066D1 (en) DIHYDROTHIENOPYRIMIDINE FOR THE TREATMENT OF INFLAMMATORY DISEASES
DE602005007717D1 (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
DE602005026984D1 (en) CHINOLIN DERIVATIVES FOR THE TREATMENT OF LATENTE Tuberculosis
DE602005015577D1 (en) UML ANTAGONISTS OF THE P2Y1 RECEPTOR FOR THE TREATMENT OF THROMBOSELEIDES
ATE512948T1 (en) BIPHENYL-SULFONYL AND PHENYL-HETEROARYL-SULFONYL MODULATORS OF THE HISTAMINE H3 RECEPTOR FOR THE TREATMENT OF RELATED DISEASES
DE602006010449D1 (en) TREATMENT OF POULTRY FOR THE REDUCTION OF FUTON ASCITES
BRPI0820440A2 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders.
ATE483460T1 (en) AMINO-OXO-INDOLYLIDE COMPOUNDS FOR USE IN THE TREATMENT OF ITCHY SCALP
DE602006003094D1 (en) 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCHINOLINE DERIVATIVES FOR THE TREATMENT OF BARRENESS
DE602006007323D1 (en) USE OF BAFF FOR THE TREATMENT OF TH2-INDUCED SUFFERING
ATE504297T1 (en) VISNADIN FOR THE TREATMENT OF ITCH OF THE SCALP
DE602005016141D1 (en) S-MIRTAZAPINE FOR THE TREATMENT OF HITZEWALLUNGEN
ATE503752T1 (en) SULFAMIDE ALSENDOTHELIN RECEPTOR ANTAGONSITES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
DE602007008759D1 (en) PYRROLOA1,2-AIMIDAZOLDION FOR THE TREATMENT OF PERIPHERAL NEUROTOXICITY BY CHEMOTHERAPEUTIC AGENTS
DE602004011679D1 (en) Treatment of disorders

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties